Cover Image

A report of stable segmental vitiligo with exacerbations following Oxford-AstraZeneca and MVC-COV1901 COVID-19 vaccinations

Saved in:

Bibliographic Details
Main Authors:	Tsung-Fu Tsai (Author), Chau Yee Ng (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2022-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Busting the Breast Cancer with AstraZeneca's Gefitinib
by: S. Chemmalar, et al.
Published: (2023)

Rhabdomyolysis following Oxford/AstraZeneca COVID-19 vaccination; two case reports from Iran
by: Marzieh Hashemi, et al.
Published: (2024)

Psoriatic flare following Oxford-AstraZeneca ChAdOx1 COVID-19 and influenza vaccines
by: Natalie Teh, et al.
Published: (2021)

Cutaneous lupus erythematosus flare with vitiligo-like depigmentation following the AstraZeneca COVID vaccine
by: Farrah Bakr, MBBS, MRCP, et al.
Published: (2022)

Lipschütz ulcers after AstraZeneca COVID-19 vaccination
by: Maria Bracho-Borro, et al.
Published: (2023)

A study of SARS-CoV-2 delta variant breakthrough infections and side effects of the Oxford-AstraZeneca vaccine
by: Nawfal R. Hussein, et al.
Published: (2022)

Side Effects Following Administration of the First Dose of Oxford-AstraZeneca's Covishield Vaccine in Bangladesh: A Cross-Sectional Study
by: Nishat Jahan, et al.
Published: (2021)

Technological order and technology transfer of the vaccine for COVID-19 in Brazil: a case study of the model used by AstraZeneca/Oxford and Fiocruz
by: Silvania lacovino Dantas, et al.
Published: (2022)

New-onset bullous pemphigoid triggered by AstraZeneca COVID-19 vaccine
by: Yin-Cheng Chao, et al.
Published: (2022)

[Translated article] Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine
by: N. González-Romero, et al.
Published: (2022)

The knowledge, attitudes, and perceptions toward the Oxford AstraZeneca COVID-19 vaccine amongst Primary Health care workers in North-Central Trinidad
by: Raveed Khan, et al.
Published: (2023)

A case of acute transverse myelitis following the AstraZeneca COVID-19 vaccine
by: Reema Madike, et al.
Published: (2023)

A case of pityriasis rubra pilaris following AstraZeneca COVID-19 vaccine
by: Miki Wada, BMedSc, MD, et al.
Published: (2022)

Acquired Thrombotic Thrombocytopenic Purpura after AstraZeneca Vaccine: a Case Report
by: Fatemeh Yaghoobi, et al.
Published: (2022)

The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence
by: Luis Rosero-Bixby
Published: (2022)

Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study
by: Elias Ali Yesuf, et al.
Published: (2022)

ANALISIS FRAMING PEMBERITAAN VAKSIN COVID-19 OXFORD-ASTRAZENECA DI INDONESIA(Studi Pada Pemberitaan Media Kompas.com & Tempo.co Tanggal 14 - 30 Juni 2021 Dalam Pemberitaan Vaksin Oxford-AstraZeneca)
by: Dian Rahmawati Subakti,
Published: (2022)

Radiation recall dermatitis triggered by the AstraZeneca COVID-19 vaccine: A case report and literature review
by: Ya-Wen Tsai, et al.
Published: (2022)

Zoster infection after vaccination with the AstraZeneca COVID-19 vaccine: A case report
by: Laurent Dupoirieux
Published: (2022)

Drug reaction with eosinophilia and systemic symptoms syndrome following vaccination with the AstraZeneca COVID-19 vaccine
by: Thomas O'Connor, et al.
Published: (2022)

Infographics on risks associated with COVID-19 and the willingness to get the AstraZeneca vaccine: two randomized online experiments
by: Lisa Felgendreff, et al.
Published: (2024)

Úlceras de Lipschütz tras la vacuna frente a la COVID-19 de AstraZeneca
by: N. González-Romero, et al.
Published: (2022)

Autoimmune Hepatitis after AstraZeneca Coronavirus Disease 2019 (COVID-19) vaccine: need for epidemiological study
by: Sofia Bizarro Ponte, et al.
Published: (2022)

Evaluation and comparison of post-vaccination adverse effects among Janssen and Oxford-AstraZeneca vaccinated adult individuals in Debre Tabor Town: A cross- sectional survey in Northwest Ethiopia
by: Endeshaw Chekol Abebe, et al.
Published: (2022)

How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany's AstraZeneca controversy
by: Jan Priebe, et al.
Published: (2022)

Vaccine efficacy against SARS-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines: a systematic review
by: Lia Reynolds, et al.
Published: (2023)

Humoral anti-SARS-CoV-2 immune response for different strains after Sinovac-CoronaVac and Oxford/AstraZeneca (ChAdOx1-S) full vaccination on a healthcare population in Brazil
by: Maicon Jeferson Silva de Oliveira, et al.
Published: (2024)

Astra zeneca Covid vaccination conversion reaction
by: Roy G Beran
Published: (2021)

A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran
by: Shahin Soltani, et al.
Published: (2023)

Factors associated with initial AstraZeneca vaccine knowledge, attitudes, and uptake among hospital nurses: A cross-sectional study in Ghana's Upper East region.
by: Simon Ferguson Atongu, et al.
Published: (2024)

Gender disparities and associated factors to intention to getting a second dose of COVID-19 AstraZeneca vaccine among adult populations in selected facilities of Lusaka, Zambia.
by: Choolwe Jacobs, et al.
Published: (2022)

Gender disparities and associated factors to intention to getting a second dose of COVID-19 AstraZeneca vaccine among adult populations in selected facilities of Lusaka, Zambia
by: Choolwe Jacobs, et al.
Published: (2022)

Utilization of health care services before and after media attention about fatal side effects of the AstraZeneca vaccine: a nation-wide register-based event study
by: Vilde Bergstad Larsen, et al.
Published: (2021)

Comparative immunogenicity and neutralizing antibody responses post heterologous vaccination with CoronaVac (Sinovac) and Vaxzevria (AstraZeneca) in HIV-infected patients with varying CD4+ T lymphocyte counts
by: Sorawit Chittrakarn, et al.
Published: (2024)

Effectiveness of AstraZeneca vaccine against SARS-CoV-2 (ChAdox1-S) in reducing in-hospital mortality in individuals with COVID-19 and schizophrenia: A retrospective cohort study
by: Tiffany Dyu, et al.
Published: (2024)

Pregnant and Breastfeeding Mothers Who Have Received the ChAdOx1 AstraZeneca COVID-19 Vaccine May Have Infants with an Increased Risk of Zinc Insufficiency and SCID Disease
by: Amr Ahmed, et al.
Published: (2023)

Thromboembolism after Astra Zeneca COVID-19 vaccine: Not always PF4- antibody mediated
by: Sascha d'Almeida, et al.
Published: (2023)

SARS‑CoV‑2 IgG antibody status in unvaccinated and 2‑dose vaccinated Indonesians by Astra Zeneca
by: Laura Yamani, et al.
Published: (2023)

From zero to one: Recent advances in the pathogenesis, diagnosis, and treatment of vitiligo
by: Peng-Chieh Shen, et al.
Published: (2023)

Clinical effect of concentrated growth factors coating in the treatment of stable segmental vitiligo with autologous epidermal transplantation
by: Feixiang FAN, et al.
Published: (2022)